Literature DB >> 11967985

Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling.

Madhusoodana P Nambiar1, Vishal G Warke, Carolyn U Fisher, George C Tsokos.   

Abstract

Trichostatin A (TSA) is a potent reversible inhibitor of histone deacetylase, and it has been reported to have variable effects on the expression of a number of genes. In this report, we show that TSA suppresses the expression of the T cell receptor zeta chain gene, whereas, it upregulates the expression if its homologous gene Fc(epsilon) receptor I gamma chain. These effects are associated with decreased intracytoplasmic-free calcium responses and altered tyrosine phosphorylation pattern of cytosolic proteins. Along with these effects, we report that TSA suppresses the expression of the interleukin-2 gene. The effects of TSA on human T cells are predominantly immunosuppressive and reminiscent of the signaling aberrations that have been described in patients with systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967985     DOI: 10.1002/jcb.10160

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

1.  The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus.

Authors:  Kathleen E Sullivan; April Suriano; Kelly Dietzmann; Janice Lin; Daniel Goldman; Michelle A Petri
Journal:  Clin Immunol       Date:  2007-02-05       Impact factor: 3.969

Review 2.  Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Christian M Hedrich; George C Tsokos
Journal:  Trends Mol Med       Date:  2011-08-30       Impact factor: 11.951

3.  Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

Authors:  Nilamadhab Mishra; Christopher M Reilly; Doris R Brown; Phil Ruiz; Gary S Gilkeson
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

4.  cAMP-responsive element modulator (CREM)α protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus.

Authors:  Christian M Hedrich; Thomas Rauen; George C Tsokos
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

5.  cAMP-responsive element modulator (CREM)α protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus.

Authors:  Thomas Rauen; Christian M Hedrich; Yuang-Taung Juang; Klaus Tenbrock; George C Tsokos
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

Review 6.  HDAC inhibition in lupus models.

Authors:  Christopher M Reilly; Nicole Regna; Nilamadhab Mishra
Journal:  Mol Med       Date:  2011-02-11       Impact factor: 6.354

Review 7.  The real culprit in systemic lupus erythematosus: abnormal epigenetic regulation.

Authors:  Haijing Wu; Ming Zhao; Christopher Chang; Qianjin Lu
Journal:  Int J Mol Sci       Date:  2015-05-15       Impact factor: 5.923

8.  Alterations in nuclear structure promote lupus autoimmunity in a mouse model.

Authors:  Namrata Singh; Duncan B Johnstone; Kayla A Martin; Italo Tempera; Mariana J Kaplan; Michael F Denny
Journal:  Dis Model Mech       Date:  2016-06-09       Impact factor: 5.758

Review 9.  Translating epigenetics into clinic: focus on lupus.

Authors:  Zijun Wang; Christopher Chang; Mou Peng; Qianjin Lu
Journal:  Clin Epigenetics       Date:  2017-08-02       Impact factor: 6.551

10.  Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes.

Authors:  Z Zhang; L Song; K Maurer; M A Petri; K E Sullivan
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.